20 May 2013
Keywords: launches, risperdal, m-tab, usa, launch, johnson, new
Article | 12 May 2003
The US launch of Johnson & Johnson's new fast-dissolve formulation of its atypical antipsychotic Risperdal (risperidone), called Risperdal
M-Tab, was due ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 May 2003
26 May 2003
28 April 2003
© 2013 thepharmaletter.com